Showing results (431-440 of 501) with videos related to
Sort By:
Pageof 51
Leukemia & Lymphoma|June 9, 2011
Multicenter phase II trial of enzastaurin in patients with relapsed or refractory advanced cutaneous T-cell lymphomaChristiane Querfeld, Timothy M Kuzel, Youn H Kim, et al.Plos One|August 15, 2019
Virtual reality for management of pain in hospitalized patients: A randomized comparative effectiveness trialBrennan Spiegel, Garth Fuller, Mayra Lopez, et al.Journal of Oncology Practice|July 2, 2013
Acute kidney injury and bisphosphonate use in cancer: a report from the research on adverse drug events and reports (RADAR) projectBeatrice J Edwards, Sarah Usmani, Dennis W Raisch, et al.Clinical Lymphoma, Myeloma & Leukemia|June 14, 2020
Outcomes of Patients with Transformed Mycosis Fungoides: Analysis from a Prospective Multicenter US Cohort StudyFrederick Lansigan, Steven M Horwitz, Lauren C Pinter-Brown, et al.Blood Advances|February 14, 2025
Phase 1 trial of durvalumab (anti-PD-L1) combined with lenalidomide in relapsed/refractory cutaneous T-cell lymphomaChristiane Querfeld, Joycelynne Palmer, Zhen Han, et al.The Journal of Pharmacology and Experimental Therapeutics|May 1, 1996
Characterization of CP-122,721; a nonpeptide antagonist of the neurokinin NK1 receptorS McLean, A Ganong, P A Seymour, et al.The Journal of Investigative Dermatology|May 15, 2018
Multi-Kinase Inhibitor with Anti-p38γ Activity in Cutaneous T-Cell LymphomaXu Hannah Zhang, Sangkil Nam, Jun Wu, et al.Postgraduate Medicine|September 24, 1999
Safety of itraconazole pulse therapy for onychomycosis. An updateP De Doncker, A K Gupta, J Q Cel Rosso, et al.Blood|December 12, 2018
Regulation of SOX11 expression through CCND1 and STAT3 in mantle cell lymphomaAtish Mohanty, Natalie Sandoval, An Phan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2009
The novel expanded porphyrin, motexafin gadolinium, combined with [90Y]ibritumomab tiuxetan for relapsed/refractory non-Hodgkin's lymphoma: preclinical findings and results of a phase I trialAndrew M Evens, William G Spies, Irene B Helenowski, et al.Pageof 51